Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Broder

Showing results (91-100 of 451) with videos related to

Pageof 46
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
Therapy of AIDS and AIDS-associated neoplasmsJ M Pluda, S Broder, R Yarchoan
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
The occurrence of opportunistic non-Hodgkin's lymphomas in the setting of infection with the human immunodeficiency virusJ M Pluda, R Yarchoan, S Broder
Current Concepts in Nutrition|January 1, 1977
Protein-losing enteropathy in malignancyT A Waldmann, S Broder, W Strober
Journal of Medicinal Chemistry|July 1, 1988
1-(2,3-Anhydro-beta-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virusT R Webb, H Mitsuya, S Broder
Annals of the New York Academy of Sciences|January 1, 1974
Protein-losing enteropathies in malignancyT A Waldmann, S Broder, W Strober
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1991
Targeted therapy of human immunodeficiency virus-related diseaseH Mitsuya, R Yarchoan, S Kageyama, et al.
Archives of Internal Medicine|January 1, 1982
Chemotherapy for lymphoma in a patient with common variable immunodeficiency: case report, literature review, and recommendations for chemotherapy in immunodeficient patientsE Gelmann, T Anderson, E Jaffe, et al.
Journal of Healthcare Leadership|May 31, 2022
An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19Michael S Broder, Sarah N Gibbs, Irina Yermilov
Cancer Research|September 1, 1985
Implications of the discovery of HTLV-III for the treatment of AIDSR Yarchoan, H Mitsuya, S Matsushita, et al.
The Journal of Experimental Medicine|January 1, 1980
Participation of suppressor T cells in the immunosuppressive activity of a heteroantiserum to human Ia-like antigens (p23,30)S Broder, D L Mann, T A Waldmann
Pageof 46

Showing results (91-100 of 451) with videos related to

Sort By:
Pageof 46
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
Therapy of AIDS and AIDS-associated neoplasmsJ M Pluda, S Broder, R Yarchoan
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
The occurrence of opportunistic non-Hodgkin's lymphomas in the setting of infection with the human immunodeficiency virusJ M Pluda, R Yarchoan, S Broder
Current Concepts in Nutrition|January 1, 1977
Protein-losing enteropathy in malignancyT A Waldmann, S Broder, W Strober
Journal of Medicinal Chemistry|July 1, 1988
1-(2,3-Anhydro-beta-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virusT R Webb, H Mitsuya, S Broder
Annals of the New York Academy of Sciences|January 1, 1974
Protein-losing enteropathies in malignancyT A Waldmann, S Broder, W Strober
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1991
Targeted therapy of human immunodeficiency virus-related diseaseH Mitsuya, R Yarchoan, S Kageyama, et al.
Archives of Internal Medicine|January 1, 1982
Chemotherapy for lymphoma in a patient with common variable immunodeficiency: case report, literature review, and recommendations for chemotherapy in immunodeficient patientsE Gelmann, T Anderson, E Jaffe, et al.
Journal of Healthcare Leadership|May 31, 2022
An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19Michael S Broder, Sarah N Gibbs, Irina Yermilov
Cancer Research|September 1, 1985
Implications of the discovery of HTLV-III for the treatment of AIDSR Yarchoan, H Mitsuya, S Matsushita, et al.
The Journal of Experimental Medicine|January 1, 1980
Participation of suppressor T cells in the immunosuppressive activity of a heteroantiserum to human Ia-like antigens (p23,30)S Broder, D L Mann, T A Waldmann
Pageof 46